SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-151724
Filing Date
2021-05-05
Accepted
2021-05-05 16:13:00
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A d305015ddefa14a.htm DEFA14A 33807
2 GRAPHIC g305015g22i22.jpg GRAPHIC 57998
3 GRAPHIC g305015g69s75.jpg GRAPHIC 110292
4 GRAPHIC g305015sp002.jpg GRAPHIC 1224
  Complete submission text file 0001193125-21-151724.txt   268531
Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39401 | Film No.: 21893384
SIC: 2836 Biological Products, (No Diagnostic Substances)